In India, the Russian-developed Corona Vaccine Sputnik V has been approved for emergency use. This is the third vaccine for the coronavirus to be approved after Kovshield (Serum Institute of India) and Kovaxin (Bharat Biotech).
The Sputnik V vaccine, developed by Moscow's Gamale National Research Institute of Epidemiology and Microbiology, uses two different viruses that cause the common cold (adenovirus) in humans. Adenovirus becomes weak so it cannot replicate in humans and cannot cause disease.
Let me tell you that this vaccine is also modified. For this reason, the vaccine provides a code for making the coronavirus spike protein. The purpose of this process is to ensure that when the actual virus tries to infect the body, it can mount an immune response in the form of antibodies.
Sputnik uses a different vector for each of the two shots during vaccination. According to this Russian Direct Investment Fund (RDIF), the same methods are used for both shots. It provides immunity with a longer duration than other vaccines. A difference of 21 days is required for both shots.
Sputnik V (liquid) is stored at a temperature of minus 18 ° C. However, its dried form can be stored at 2–8 ° C. This does not require investing in cold-chain infrastructure. According to the RDIF, Sputnik V has been approved for the use of more than 150 crore people in 55 countries. The vaccine is proposed to be priced below $ 10 per shot. Although its price in India has not been decided.
Dr. Reddy's labs based in Hyderabad sought government approval for the vaccine in India. RDIF partnered with Dr. Reddy's in September 2020 to conduct clinical trials in the country. On Monday, the Subject Expert Committee (SEC) of the Drugs Controller General of India took the Sputnik V application for Emergency Use Authority and moved on. DCGI previously sought additional data from the drug manufacturer.
Five other Indian companies have partnered with RDIF for Sputnik V. These include Gland Pharma, Hetero Biopharma, Virchow Biotech, Panacea Biotech, and Stellis Biopharma, Bangalore-based Strides Pharma Science's bioceramic. It is expected from their partnerships that India's capacity to manufacture this vaccine will exceed 60 million.
Jyoti Malhotra's father Harish Malhotra, accused of espionage, said on Thursday that he did not h
Sheikh Rashid, the big-hearted minister of the Imran government of Pakistan, has become a problem
A resolution has been brought to the Municipal Corporation's house demanding to change the name o
Balasaheb's loyal servant left Uddhav's side; for 30 years he served in Matoshree, now Shinde joined
Once very close to Shiv Sena supremo Balasaheb Thackeray and one of the loyalists of his residenc
Virat Kohli on Ben Stokes Century ENG vs AUS In the second Test match of the Ashes series, Austra
The Indian team, led by Suryakumar Yadav, maintained its unbeaten run in the Asia Cup, defeating
How the Bharatiya Janata Yuva Morcha (BJYM) city president Praveen Nettaru (32) was murdered in M
New Labor Code: Modi government is going to bring a new labor law. If it came into effect from 1s
After taking 24 wickets in the ODI World Cup 2023, Mohammed Shami has joined the list of the most
During the IPL for the last few days, you must have seen the advertisement for TATA Neu App every
